Serum levels of the adipokine zinc-α2-glycoprotein are increased in chronic hemodialysis

Metabolism: Clinical and Experimental

Volumn 60, Issue 5, 2011, Pages 669-672

  Philipp, Anne ^a   Kralisch, Susan ^a   Bachmann, Anette ^a   Lossner, Ulrike ^a   Kratzsch, Jürgen ^a   Blüher, Matthias ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; INSULIN; LEPTIN; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HEMODIALYSIS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FASTING; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; KIDNEY; LEPTIN; LIPID METABOLISM; MALE; MIDDLE AGED; RENAL DIALYSIS; SEMINAL PLASMA PROTEINS;

EID: 79955031569     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.06.019     Document Type: Article

References (26)

1. Kahn B.B., and Flier J.S. Obesity and insulin resistance J Clin Invest 106 2000 473 481 (Pubitemid 30666380)
2. Kiberstis P.A. A surfeit of suspects Science 307 2005 369 (Pubitemid 40139969)
3. Saltiel A.R. The molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases J Clin Invest 106 2000 163 164 (Pubitemid 30483116)
4. Bing C., Bao Y., and Jenkins J. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia Proc Natl Acad Sci U S A 101 2004 2500 2505 (Pubitemid 38269340)
5. Rolli V., Radosavljevic M., and Astier V. Lipolysis is altered in MHC class I zinc-alpha(2)-glycoprotein deficient mice FEBS Lett 581 2007 394 400 (Pubitemid 46157227)
6. Hirai K., Hussey H.J., Barber M.D., Price S.A., and Tisdale M.J. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients Cancer Res 58 1998 2359 2365 (Pubitemid 28252695)
7. Russell S.T., Zimmerman T.P., Domin B.A., and Tisdale M.J. Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein Biochim Biophys Acta 1636 2004 59 68 (Pubitemid 38231005)
8. Gong F.Y., Zhang S.J., and Deng J.Y. Zinc-alpha2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue Int J Obes (Lond) 33 2009 1023 1030
9. Bao Y., Bing C., and Hunter L. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes FEBS Lett 579 2005 41 47 (Pubitemid 40023371)
10. Mracek T., Ding Q., and Tzanavari T. The adipokine zinc-alpha2- glycoprotein is downregulated with fat mass expansion in obesity Clin Endocrinol (Oxf) 72 2010 334 341
11. Gohda T., Makita Y., and Shike T. Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity? Diabetes 52 2003 2175 2181 (Pubitemid 36919814)
12. Selva D.M., Lecube A., and Hernandez C. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance J Clin Endocrinol Metab 94 2009 4499 4507
13. Ceperuelo-Mallafre V., Naf S., and Escote X. Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat J Clin Endocrinol Metab 94 2009 5062 5069
14. Stejskal D., Karpisek M., and Reutova H. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA Clin Biochem 41 2008 313 316
15. Yeung D.C., Lam K.S., Wang Y., Tso A.W., and Xu A. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects J Clin Endocrinol Metab 94 2009 2531 2536
16. Zoccali C., Mallamaci F., and Tripepi G. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease J Am Soc Nephrol 13 2002 134 141 (Pubitemid 34042020)
17. Merabet E., Dagogo-Jack S., and Coyne D.W. Increased plasma leptin concentration in end-stage renal disease J Clin Endocrinol Metab 82 1997 847 850 (Pubitemid 27106599)
18. Ziegelmeier M., Bachmann A., and Seeger J. Serum levels of the adipokine RBP-4 in relation to renal function Diabetes Care 30 2007 2588 2592 (Pubitemid 47547801)
19. Sommer G., Ziegelmeier M., and Bachmann A. Serum levels of adipocyte fatty acid binding protein are increased in chronic haemodialysis Clin Endocrinol (Oxf) 69 2008 901 905
20. Stein S., Bachmann A., and Lossner U. Serum levels of the adipokine FGF21 depend on renal function Diabetes Care 32 2009 126 128
21. Pfau D., Bachmann A., and Lossner U. Serum levels of the adipokine chemerin in relation to renal function Diabetes Care 33 2010 171 173
22. Seeger J., Ziegelmeier M., and Bachmann A. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters J Clin Endocrinol Metab 93 2008 247 251
23. Fasshauer M., Bluher M., and Stumvoll M. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function Clin Endocrinol (Oxf) 66 2007 434 439 (Pubitemid 46239304)
24. Kratzsch J., Berthold A., and Lammert A. A rapid, quantitative immunofunctional assay for measuring human leptin Horm Res 57 2002 127 132 (Pubitemid 34507626)
25. Lee D.M., Knight-Gibson C., and Samuelsson O. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency Kidney Int 61 2002 209 218 (Pubitemid 34075149)
26. Pupim L.B., Flakoll P.J., and Ikizler T.A. Protein homeostasis in chronic hemodialysis patients Curr Opin Clin Nutr Metab Care 7 2004 89 95 (Pubitemid 40348188)